Wegovy's cardiovascular indication rests on a large outcomes trial described in its label, in which 8,803 patients were exposed to Wegovy for a median of 37.3 months and 8,801 to placebo for a median of 38.6 months, with a primary endpoint of time to first cardiovascular death, nonfatal myocardial infarction or nonfatal stroke
Improvements in HbA1c and lipids for adults receiving tirzepatide were also observed
But she also likened being on Ozempic to doctor-approved anorexia, and said she felt addicted to losing weight on the drug
Regular Check-ups: Visit your healthcare provider for regular check-ups and screenings to monitor your liver health
If you have swollen feet accompanied by other worrying symptoms, its absolutely crucial to seek medical attention promptly
Glutathionylated roGFP2 is subsequently reduced via the monothiol ping-pong mechanism for GSSR substrates